RecallDepth
Class II Terminated

Alprostadil Injection USP 500 micrograms/mL 1 mL single use vial, 5 vials per carton, Rx only, TEVA Pharmaceuticals USA, Inc., North Wales, PA --- NDC 0703-1501-02

Company
Teva Pharmaceuticals Usa
Recall Initiated
September 27, 2018
Posted
November 21, 2018
Recall Number
D-0244-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,362 vials
Firm Location
North Wales, PA, United States

Reason for Recall

Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing

Distribution

Product was distributed throughout the United States, including Hawaii and Puerto Rico.

Lot / Code Info

Lot # 31323147B, exp. date 01/2019

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls